Related Experiment Video
Updated: Jul 4, 2025
09:52
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
7.5K
RNF20 contributes to epigenetic immunosuppression through CDK9-dependent LSD1 stabilization.
Bo Dong1,2, Xinzhao Wang1,2,3, Xiang Song1,2,3,4
1Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY 40508.
Summary
Cyclin-dependent kinase 9 (CDK9) regulates gene silencing and immune suppression. Its interaction with RNF20 stabilizes LSD1, impacting cancer immunotherapy sensitivity.
Area of Science:
- Epigenetics
- Cancer Biology
- Immunology
Background:
- Cyclin-dependent kinase 9 (CDK9) is vital for transcription and gene silencing.
- CDK9 inhibition enhances immunotherapy sensitivity, but the mechanism is unknown.
- Epigenetic regulation influences immune responses in cancer.
Purpose of the Study:
- To elucidate the mechanism by which CDK9 inhibition impacts cancer immunotherapy.
- To investigate the role of RNF20 and LSD1 in CDK9-mediated immunosuppression.
- To explore the therapeutic potential of targeting the CDK9-RNF20-LSD1 axis.
Main Methods:
- Investigated CDK9-RNF20-LSD1 interactions using ubiquitination and phosphorylation assays.
- Assessed the impact of RNF20 and LSD1 on histone H3K4 demethylation and retroviral repression.
- Evaluated the effect of RNF20 loss on anti-PD-1 immunotherapy response in vivo.
- Correlated RNF20 and LSD1 levels in human breast cancer samples.
Main Results:
- RNF20 stabilizes LSD1 through CDK9-dependent phosphorylation and ubiquitination.
- This stabilization is essential for histone H3K4 demethylation, retroviral repression, and epigenetic immunosuppression.
- Loss of RNF20 sensitizes cancer cells to anti-PD-1 therapy, an effect reversible by LSD1.
- RNF20 and LSD1 levels are positively correlated in human breast cancer.
Conclusions:
- RNF20 plays a critical role in CDK9-dependent LSD1 stabilization, mediating epigenetic silencing and immunosuppression.
- Targeting the CDK9-RNF20-LSD1 pathway offers a potential strategy for enhancing cancer immunotherapy.
More Related Videos
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
1.4K
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.6K
Related Concept Videos
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
03:17Inheritance of Chromatin Structures
6.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.2K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
01:24Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K